What does this research mean for the field?

The study identifies a novel evasin that inhibits both CC and CXC chemokines, demonstrating its potential as a unique therapeutic agent. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To identify and characterize a distinct evasin that inhibits chemokines involved in immune responses.

synapse

⌘+K

synapse

⌘+K

February 28, 2026Open Access

Discovery of an evolutionarily distinct evasin with dual CC and CXC chemokine inhibitory activity

Key Points

To identify and characterize a distinct evasin that inhibits chemokines involved in immune responses.
Utilization of biochemical assays to assess chemokine activity
Comparison with existing evasins
Evolutionary analysis to understand distinctiveness
The newly discovered evasin effectively inhibits both CC and CXC chemokines
Demonstrated unique structural features compared to other evasins
Potential therapeutic applications in modulating immune responses

Abstract

Publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies including Cell, Neuron, Immunity, Current Biology, AJHG, and the Trends Journals.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Kunwar et al. (Sun,) studied this question.

synapsesocial.com/papers/69a286eb0a974eb0d3c02372 https://doi.org/https://doi.org/10.1016/j.str.2026.02.001

Bookmark

View Full Paper